Is pathologic complete remission a useful measure of response to novel therapies in neoadjuvant trials? Commentary

Alexandra Leary, Ian Smith

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish
Pages (from-to)126-127
Number of pages2
JournalNature Clinical Practice Oncology
Volume3
Issue number3
DOIs
Publication statusPublished - 1 Mar 2006
Externally publishedYes

Keywords

  • Breast cancer
  • Complete remission
  • Disease-free survival
  • Neoadjuvant
  • Pathologic response

Cite this